{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:03:29Z","timestamp":1790366609992,"version":"4.1.0"},"reference-count":44,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Particip Med"],"abstract":"Abstract<\/jats:title>\n \n Background<\/jats:title>\n Dravet syndrome is a complex developmental and epileptic encephalopathy characterized by treatment-resistant seizures and multiple comorbidities that significantly affect quality of life. Traditional clinic-based assessments often fail to capture real-world functional abilities and behavioral changes.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n This study aimed to (1) identify caregiver-prioritized meaningful aspects of health, (2) co-design digital assessment modalities for home use, and (3) generate preliminary usability and implementation insights to inform future clinical research.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n A multistage patient and public involvement activity was conducted between November 2023 and October 2025 in Spain, in collaboration with a patient advocacy organization and a digital health company. Participants were recruited through the Fundaci\u00f3n S\u00edndrome de Dravet using a convenience opt-in sampling approach. The process included a caregiver survey to identify meaningful aspects of health, a design workshop to refine priorities and technology preferences, and a 2-week usability testing of a prototype app, followed by a feedback workshop. Data were analyzed descriptively to inform iterative cocreation; no hypothesis testing was performed.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Fifty caregivers completed the survey. Neuropsychiatric symptoms (17\/48, 35%), independence (16\/48, 33%), and social or leisure activities (15\/48, 31%) were the most commonly reported affected domains. Eight caregivers participated in the design workshop, emphasizing flexibility, age-appropriate tasks, and reduced reporting burden. Usability testing was conducted with 5 caregivers over 2 weeks, with 4 of 5 caregivers providing feedback. Participants reported a generally positive reception of the digital tools, particularly customizable task selection and open-text fields, while identifying challenges related to video-recording logistics and questionnaire repetition. Feedback underscored the need for simplified workflows and individualized approaches to maintain engagement.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n Cocreation with caregivers is feasible and appears essential for developing meaningful digital outcome measures for Dravet syndrome. Video-based tasks and remote reporting tools show promise for capturing motor, cognitive, and behavioral domains beyond seizure frequency. Future work should focus on iterative refinement and formal validation of these measures as end points in clinical trials, ensuring that they reflect outcomes that matter most to patients and families.<\/jats:p>\n <\/jats:sec>","DOI":"10.2196\/92512","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T15:35:23Z","timestamp":1782228923000},"page":"e92512-e92512","source":"Crossref","is-referenced-by-count":0,"title":["Cocreation of Digital Outcome Measures for Dravet Syndrome: Multistage Co-Design Feasibility Study"],"prefix":"10.2196","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4309-1515","authenticated-orcid":false,"given":"Navdeep","family":"Sahota","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9431-6759","authenticated-orcid":false,"given":"Simona","family":"Giorgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3387-218X","authenticated-orcid":false,"given":"Ana","family":"Cant\u00f3 Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5568-2834","authenticated-orcid":false,"given":"Naiara","family":"S\u00e1nchez Marco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9345-8659","authenticated-orcid":false,"given":"Elisa","family":"Ferrer Mallol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4987-0088","authenticated-orcid":false,"given":"Elin","family":"Haf Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7779-7626","authenticated-orcid":false,"given":"Jos\u00e9 \u00c1ngel","family":"Aibar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"issue":"2","key":"R1","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/j.1528-1167.2010.02925.x","article-title":"Cognitive development in Dravet syndrome: a retrospective, multicenter study of 26 patients","volume":"52","author":"Ragona","journal-title":"Epilepsia"},{"issue":"6","key":"R2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.5006","article-title":"Dravet syndrome: an overview","volume":"11","author":"Anwar","journal-title":"Cureus"},{"issue":"2","key":"R3","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/epi.16810","article-title":"The severe epilepsy syndromes of infancy: a population-based study","volume":"62","author":"Howell","journal-title":"Epilepsia"},{"key":"R4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-8749.2011.03964.x","article-title":"Dravet syndrome history","volume":"53 Suppl 2","author":"Dravet","journal-title":"Dev Med Child Neurol"},{"issue":"s2","key":"R5","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/j.1528-1167.2011.03007.x","article-title":"The pharmacologic treatment of Dravet syndrome","volume":"52 Suppl 2","author":"Chiron","journal-title":"Epilepsia"},{"key":"R6","doi-asserted-by":"publisher","DOI":"10.1017\/cjn.2016.249","article-title":"Treatment of Dravet syndrome","volume":"43 Suppl 3","author":"Wirrell","journal-title":"Can J Neurol Sci"},{"key":"R7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2011.02999.x","article-title":"Cognitive and behavioral characteristics of children with Dravet syndrome: an overview","volume":"52 Suppl 2","author":"Guzzetta","journal-title":"Epilepsia"},{"issue":"8","key":"R8","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1111\/j.1528-1167.2011.03129.x","article-title":"Comorbidities and predictors of health-related quality of life in Dravet syndrome","volume":"52","author":"Brunklaus","journal-title":"Epilepsia"},{"issue":"1","key":"R9","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-98517-4","article-title":"Clinical spectrum and the comorbidities of Dravet syndrome in Taiwan and the possible molecular mechanisms","volume":"11","author":"Huang","journal-title":"Sci Rep"},{"key":"R10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2011.02994.x","article-title":"The core Dravet syndrome phenotype","volume":"52 Suppl 2","author":"Dravet","journal-title":"Epilepsia"},{"issue":"1","key":"R11","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/dmcn.13591","article-title":"Quality of life and comorbidities associated with Dravet syndrome severity: a multinational cohort survey","volume":"60","author":"Lagae","journal-title":"Dev Med Child Neurol"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2017.06.031","article-title":"Dravet syndrome: characteristics, comorbidities, and caregiver concerns","volume":"74","author":"Villas","journal-title":"Epilepsy Behav"},{"issue":"11","key":"R13","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14113769","article-title":"Feasibility of an app-assisted and home-based video version of the Timed Up and Go test for patients with Parkinson disease: vTUG","volume":"14","author":"Grobe-Einsler","journal-title":"J Clin Med"},{"issue":"5","key":"R14","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1002\/mds.28478","article-title":"Development of SARA, a new video-based tool for the assessment of Ataxia at home","volume":"36","author":"Grobe-Einsler","journal-title":"Mov Disord"},{"key":"R15","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.916714","article-title":"Patient-led development of digital endpoints and the use of computer vision analysis in assessment of motor function in rare diseases","volume":"13","author":"Ferrer-Mallol","journal-title":"Front Pharmacol"},{"issue":"6","key":"R16","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1080\/14737167.2024.2360201","article-title":"Video-based assessments of activities of daily living: generating real-world evidence in pediatric rare diseases","volume":"24","author":"Ferrer-Mallol","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-023-02813-3","article-title":"The use of digital outcome measures in clinical trials in rare neurological diseases: a systematic literature review","volume":"18","author":"Poleur","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"R18","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1097\/MCP.0000000000000972","article-title":"Digital outcome measures in pulmonary clinical trials","volume":"29","author":"Farrand","journal-title":"Curr Opin Pulm Med"},{"key":"R19","unstructured":"Digital health technologies for remote data acquisition in clinical investigations. U.S. Food and Drug Administration (FDA); 2023. URL: https:\/\/www.fda.gov\/media\/155022\/download [Accessed 04-09-2024]"},{"key":"R20","unstructured":"Send a question to the European Medicines Agency. European Medicines Agency (EMA). URL: https:\/\/www.ema.europa.eu\/en\/about-us\/contacts-european-medicines-agency\/send-question-european-medicines-agency [Accessed 04-09-2024]"},{"issue":"3","key":"R21","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1159\/000509725","article-title":"Digital measures that matter to patients: a framework to guide the selection and development of digital measures of health","volume":"4","author":"Manta","journal-title":"Digit Biomark"},{"issue":"1","key":"R22","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41591-022-02045-1","article-title":"Wearable full-body motion tracking of activities of daily living predicts disease trajectory in Duchenne muscular dystrophy","volume":"29","author":"Ricotti","journal-title":"Nat Med"},{"issue":"20","key":"R23","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1161\/CIRCULATIONAHA.115.001593","article-title":"Machine learning in medicine","volume":"132","author":"Deo","journal-title":"Circulation"},{"issue":"11","key":"R24","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1038\/s41591-018-0213-5","article-title":"The artificial intelligence clinician learns optimal treatment strategies for sepsis in intensive care","volume":"24","author":"Komorowski","journal-title":"Nat Med"},{"issue":"6","key":"R25","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1111\/epi.18338","article-title":"Updated classification of epileptic seizures: position paper of the International League Against Epilepsy","volume":"66","author":"Beniczky","journal-title":"Epilepsia"},{"key":"R26","unstructured":"Novel endpoint acceptance question bank for identifying meaningful outcome measures. Clinical Trials Transformation Initiative (CTTI); 2022. URL: https:\/\/ctti-clinicaltrials.org\/wp-content\/uploads\/2022\/03\/CTTI-Novel-Endpoint-Acceptance-Question-Bank-Outcome-Measures-FINAL.pdf [Accessed 27-11-2025]"},{"key":"R27","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2024.109958","article-title":"A tool for Dravet Syndrome-Associated Neuropsychiatric Comorbidities Evaluation (DANCE)","volume":"158","author":"Giorgi","journal-title":"Epilepsy Behav"},{"key":"#cr-split#-R28.1","unstructured":"Regulation (EU) 2016\/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data, and repealing Directive 95\/46\/EC (General Data Protection Regulation) (text with EEA relevance). European Union"},{"key":"#cr-split#-R28.2","unstructured":"Apr 27, 2016. URL: https:\/\/eur-lex.europa.eu\/eli\/reg\/2016\/679\/oj [Accessed 01-08-2026]"},{"key":"R29","unstructured":"Ley Org\u00e1nica 3\/2018, de 5 de diciembre, de Protecci\u00f3n de Datos Personales y garant\u00eda de los derechos digitales. [Article in Spanish]. Bolet\u00edn Oficial del Estado. Dec 6, 2018. URL: https:\/\/www.boe.es\/eli\/es\/lo\/2018\/12\/05\/3 [Accessed 01-08-2026]"},{"key":"R30","unstructured":"C\u00f3digo de buenas pr\u00e1cticas cient\u00edficas [Report in Spanish]. Instituto de Salud Carlos III (ISCIII); 2021. URL: https:\/\/repisalud.isciii.es\/rest\/api\/core\/bitstreams\/e55f5e68-f9e4-4b37-9f55-fb25ae4f8955\/content [Accessed 21-04-2026]"},{"issue":"7","key":"R31","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.jval.2023.05.003","article-title":"Recommendations on the selection, development, and modification of performance outcome assessments: a good practices report of an ISPOR task force","volume":"26","author":"Edgar","journal-title":"Value Health"},{"issue":"2","key":"R32","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/WCO.0000000000000902","article-title":"Dravet syndrome","volume":"34","author":"Lagae","journal-title":"Curr Opin Neurol"},{"key":"R33","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2025.110717","article-title":"What happens after the diagnosis of non-seizure symptoms in Dravet syndrome? A Brazilian national survey","volume":"173","author":"Fialho","journal-title":"Epilepsy Behav"},{"issue":"6","key":"R34","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1002\/epi4.70118","article-title":"Nonseizure symptoms and broader seizure impacts in patients with Dravet syndrome and Lennox-Gastaut syndrome in clinical practice settings: results from a multinational survey","volume":"10","author":"Shah","journal-title":"Epilepsia Open"},{"key":"R35","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2017.06.008","article-title":"Parental perception of comorbidities in children with Dravet syndrome","volume":"76","author":"Knupp","journal-title":"Pediatr Neurol"},{"issue":"9-10","key":"R36","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1111\/jocn.14755","article-title":"Parents\u2019 experiences of videoconference as a tool for multidisciplinary information exchange for children with epilepsy and disability","volume":"28","author":"Tschamper","journal-title":"J Clin Nurs"},{"key":"R37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebr.2025.100811","article-title":"Implementation of a digital health tool for seizure video transfer in a pediatric epilepsy center: a prospective pilot study","volume":"31","author":"Burger","journal-title":"Epilepsy Behav Rep"},{"issue":"4","key":"R38","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1002\/epi4.12624","article-title":"An examination of the efficacy and safety of fenfluramine in adults, children, and adolescents with Dravet syndrome in a real-world practice setting: a report from the Fenfluramine European Early Access Program","volume":"7","author":"Guerrini","journal-title":"Epilepsia Open"},{"key":"R39","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2014.03.014","article-title":"Evaluation of health-care utilization in patients with Dravet syndrome and on adjunctive treatment with stiripentol and clobazam","volume":"34","author":"Strzelczyk","journal-title":"Epilepsy Behav"},{"issue":"10","key":"R40","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-018426","article-title":"Exploring the theory, barriers and enablers for patient and public involvement across health, social care and patient safety: a protocol for a systematic review of reviews","volume":"7","author":"Ocloo","journal-title":"BMJ Open"},{"issue":"1","key":"R41","doi-asserted-by":"publisher","first-page":"671","DOI":"10.5334\/ijic.9495","article-title":"Learning from a 7 year long public patient involvement (PPI) journey with the rare disease patient organisation 22q Ireland","volume":"25","author":"Kerin","journal-title":"Int J Integr Care"},{"issue":"1","key":"R42","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-022-02561-w","article-title":"Carer burden in rare inherited diseases: a literature review and conceptual model","volume":"17","author":"Sandilands","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"R43","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-87251-w","article-title":"Perception of psychosocial burden in mothers of children with rare pediatric neurological diseases","volume":"15","author":"Walkowiak","journal-title":"Sci Rep"}],"container-title":["Journal of Participatory Medicine"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:41:23Z","timestamp":1790365283000},"score":1,"resource":{"primary":{"URL":"https:\/\/jopm.jmir.org\/2026\/1\/e92512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":44,"URL":"https:\/\/doi.org\/10.2196\/92512","relation":{},"ISSN":["2152-7202"],"issn-type":[{"value":"2152-7202","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]},"article-number":"v18i2e92512"}}